Relationship of Vasoactive Peptide Levels to Portal Pressure and Patient Outcomes in Patients With Hepatic Cirrhosis

Investigate vasoactive medicators in portal hypertension on stored sera

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Portal Hypertension Digestive System Diseases Hypertension, Portal Liver Diseases

Age range

18 year–70 year

Sex eligibility

All sexes

Study type

Observational

Primary location

Alfred Hospital

Melbourne, Victoria, 3181, Australia

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

portal hypertension

Exclusion criteria

Sponsors and collaborators

Lead sponsor

Bayside Health

Other Gov

Registry information

Important dates

First posted: Sep 14, 2005
Registry last updated: Oct 4, 2006

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.

Completed